This study evaluates the feasibility, safety and accuracy of a 19 gauge (19G) needle in nitinol in the performance of endoscopic ultrasound (EUS) guided transduodenal biopsy for the acquisition of samples for histologic analysis. Patients with lesions that can be approached only from the duodenum will be prospectively enrolled.
A 19 gauge needle in nitinol (Flex needle) has been recently become available for EUS guided procedure. The use of nitinol should guarantee a better needle flexibility with a theoretical advantage on the use of this needle for lesions that need to be sampled through the duodenum. Moreover, samples for histologic examination seems to be easy to interpret than cytologic ones allowing evaluate of the overall architecture of the tissue, better performance of immunohistochemical staining, and may be of additional value to perform tissue profiling that in the future will be very important to guide individualized therapies The existing data on the performance of the Flex needle for EUS-guided transduodenal biopsy are coming form a single study performed in one single center. Thus, the reproducibility of these results is unknown and multicenter prospective studies are warranted to answer this important question.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
246
EUS-guided fine needle biopsy performed through the duodenum with the Expect™ 19 Flex needle
Indiana Univerisity Health Medical Center
Indianapolis, Indiana, United States
Clinique du Trocadero
Paris, France
AUSL Bologna Bellaria-Maggiore Hospital
Bologna, Italy
ISMETT UPMC Italy
Palermo, Italy
Capability of Performing EUS-FNTA Through the Duodenum by Placing the Target Lesion in the Proper Position With Insertion of the Needle Into the Lesion
Number of patients in which it was possible to place the needle within the target lesion by a transduodenal route divided by the total number of enrolled patients.
Time frame: Intraoperative
Number of Complications Divided Per Total Number of Enrolled Patients
rate of complications, divided in procedural complication (perforation, bleeding) occurring during the procedure and late complications (delayed bleeding, infection) occurring during the post-procedural observational period
Time frame: intraoperative and within 3 days after the procedure
Number of Histological Samples Judged Adequate Divided by the Total Number of Patients
percentage of patients in whom a histologically interpretable specimen will be retrieved
Time frame: 5 days
Number of Correct Diagnosis Divided by the Total Number of Patients
rate of correct diagnosis obtained through analysis of the tissue samples acquired with EUS fine needle biopsy
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Digestive Endoscopy Unit, Universita' Cattolica del Sacro Cuore
Rome, Italy
Teikyo University Mizonokuchi Hospital, Departement of Gastroenterology
Kawasaki, Kanagawa, Japan